These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 24910369)

  • 81. [The clinical features, therapeutic effects and prognosis of mantle cell lymphoma].
    Zhang HX; Xu J; Liu T; Xu CG
    Zhonghua Xue Ye Xue Za Zhi; 2011 Apr; 32(4):231-5. PubMed ID: 21569704
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Prognostic significance of absolute lymphocyte count/absolute monocyte count ratio at diagnosis in patients with multiple myeloma.
    Shin SJ; Roh J; Kim M; Jung MJ; Koh YW; Park CS; Yoon DH; Suh C; Park CJ; Chi HS; Huh J
    Korean J Pathol; 2013 Dec; 47(6):526-33. PubMed ID: 24421845
    [TBL] [Abstract][Full Text] [Related]  

  • 83. A novel scoring system combining expression of CD23, CD20, and CD38 with platelet count predicts for the presence of the t(11;14) translocation of mantle cell lymphoma.
    Medd PG; Clark N; Leyden K; Turner S; Strefford JA; Butler C; Collins GP; Roberts DJ; Atoyebi W; Hatton CS
    Cytometry B Clin Cytom; 2011; 80(4):230-7. PubMed ID: 21462308
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Is ASCT with TBI superior to ASCT without TBI in mantle cell lymphoma patients?
    Peterlin P; Leux C; Gastinne T; Roland V; Mahé B; Dubruille V; Delaunay J; Chevallier P; Guillaume T; Blin N; Ayari S; Clavert A; Mohty M; Dousset C; Milpied N; Harousseau JL; Moreau P; Wuilleme S; Moreau A; Le Gouill S
    Transplantation; 2012 Aug; 94(3):295-301. PubMed ID: 22797728
    [TBL] [Abstract][Full Text] [Related]  

  • 85. High Counts of CD68+ and CD163+ Macrophages in Mantle Cell Lymphoma Are Associated With Inferior Prognosis.
    Li P; Yuan J; Ahmed FS; McHenry A; Fu K; Yu G; Cheng H; Xu ML; Rimm DL; Pan Z
    Front Oncol; 2021; 11():701492. PubMed ID: 34527580
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Prognostic significance of macrophage infiltration in leiomyosarcomas.
    Lee CH; Espinosa I; Vrijaldenhoven S; Subramanian S; Montgomery KD; Zhu S; Marinelli RJ; Peterse JL; Poulin N; Nielsen TO; West RB; Gilks CB; van de Rijn M
    Clin Cancer Res; 2008 Mar; 14(5):1423-30. PubMed ID: 18316565
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Early lymphocyte recovery after autologous stem cell transplantation predicts superior survival in mantle-cell lymphoma.
    Joao C; Porrata LF; Inwards DJ; Ansell SM; Micallef IN; Johnston PB; Gastineau DA; Markovic SN
    Bone Marrow Transplant; 2006 May; 37(9):865-71. PubMed ID: 16532015
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Rituximab plus HyperCVAD alternating with high dose cytarabine and methotrexate for the initial treatment of patients with mantle cell lymphoma, a multicentre trial from Gruppo Italiano Studio Linfomi.
    Merli F; Luminari S; Ilariucci F; Petrini M; Visco C; Ambrosetti A; Stelitano C; Caracciolo F; Di Renzo N; Angrilli F; Carella AM; Capodanno I; Barbolini E; Galimberti S; Federico M
    Br J Haematol; 2012 Feb; 156(3):346-53. PubMed ID: 22145911
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Smoldering mantle cell lymphoma.
    Ye H; Desai A; Zeng D; Nomie K; Romaguera J; Ahmed M; Wang ML
    J Exp Clin Cancer Res; 2017 Dec; 36(1):185. PubMed ID: 29246179
    [TBL] [Abstract][Full Text] [Related]  

  • 90.
    Eskelund CW; Dahl C; Hansen JW; Westman M; Kolstad A; Pedersen LB; Montano-Almendras CP; Husby S; Freiburghaus C; Ek S; Pedersen A; Niemann C; Räty R; Brown P; Geisler CH; Andersen MK; Guldberg P; Jerkeman M; Grønbæk K
    Blood; 2017 Oct; 130(17):1903-1910. PubMed ID: 28819011
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Expression of CD68+ tumor-associated macrophages in patients with diffuse large B-cell lymphoma and its relation to prognosis.
    Hasselblom S; Hansson U; Sigurdardottir M; Nilsson-Ehle H; Ridell B; Andersson PO
    Pathol Int; 2008 Aug; 58(8):529-32. PubMed ID: 18705775
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Elevated peripheral absolute monocyte count related to clinicopathological features and poor prognosis in solid tumors: Systematic review, meta-analysis, and meta-regression.
    Wen S; Chen N; Hu Y; Huang L; Peng J; Yang M; Shen X; Song Y; Xu L
    Cancer Med; 2021 Mar; 10(5):1690-1714. PubMed ID: 33591628
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Association of the numbers of CD163(+) cells in lesional skin and serum levels of soluble CD163 with disease progression of cutaneous T cell lymphoma.
    Sugaya M; Miyagaki T; Ohmatsu H; Suga H; Kai H; Kamata M; Fujita H; Asano Y; Tada Y; Kadono T; Okochi H; Sato S
    J Dermatol Sci; 2012 Oct; 68(1):45-51. PubMed ID: 22884782
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Human monocyte CD163 expression inversely correlates with soluble CD163 plasma levels.
    Davis BH; Zarev PV
    Cytometry B Clin Cytom; 2005 Jan; 63(1):16-22. PubMed ID: 15624200
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Lack of association of tumor-associated macrophages with clinical outcome in patients with classical Hodgkin's lymphoma.
    Azambuja D; Natkunam Y; Biasoli I; Lossos IS; Anderson MW; Morais JC; Spector N
    Ann Oncol; 2012 Mar; 23(3):736-742. PubMed ID: 21602260
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Deferred therapy is associated with improved overall survival in patients with newly diagnosed mantle cell lymphoma.
    Cohen JB; Han X; Jemal A; Ward EM; Flowers CR
    Cancer; 2016 Aug; 122(15):2356-63. PubMed ID: 27153197
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Genomic landscape and prognostic analysis of mantle cell lymphoma.
    Yang P; Zhang W; Wang J; Liu Y; An R; Jing H
    Cancer Gene Ther; 2018 Jun; 25(5-6):129-140. PubMed ID: 29755111
    [TBL] [Abstract][Full Text] [Related]  

  • 98. [Prognostic Significance of Progression of Disease within 24 Months in Mantle Cell Lymphoma].
    Ma RX; Zhang QQ; Chen HM; Hu J; Lu FY; Han QN; Li ZY; Xu KL; Chen W
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Jun; 32(3):702-707. PubMed ID: 38926956
    [TBL] [Abstract][Full Text] [Related]  

  • 99. [Clinical Characteristics and Prognosis of 34 Patients with Mantle Cell Lymphoma: A Retrospective Analysis].
    Chen XP; Zhao Y; Wang QS; Lv N; Li YH; Jing Y; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Dec; 23(6):1601-6. PubMed ID: 26708879
    [TBL] [Abstract][Full Text] [Related]  

  • 100. The Mantle Cell Lymphoma International Prognostic Index (MIPI) is superior to the International Prognostic Index (IPI) in predicting survival following intensive first-line immunochemotherapy and autologous stem cell transplantation (ASCT).
    Geisler CH; Kolstad A; Laurell A; Räty R; Jerkeman M; Eriksson M; Nordström M; Kimby E; Boesen AM; Nilsson-Ehle H; Kuittinen O; Lauritzsen GF; Ralfkiaer E; Ehinger M; Sundström C; Delabie J; Karjalainen-Lindsberg ML; Brown P; Elonen E;
    Blood; 2010 Feb; 115(8):1530-3. PubMed ID: 20032504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.